Cassandra Pardini, PharmD

Contributing Writer

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

Cytochromes P450 are a superfamily of enzymes containing heme as a cofactor that function as monooxygenases.

General Medicine

Drug Metabolism May Be Suppressed in Patients with Inflammatory Conditions

Cassandra Pardini, PharmD

October 18, 2021

Suppressed drug metabolism was identified in patients with various inflammatory conditions.

Stroke

Lower Stroke Risk With NOACs in Those With NVAF and High Risk for GI Bleed

Cassandra Pardini, PharmD

August 24, 2021

Findings may help with decision-making in this high-risk patient population.

Hypertension

Hypoglycemia Risk With Concomitant ACEI, Insulin Secretagogue Use

Cassandra Pardini, PharmD

August 9, 2021

The main outcome of the study was hospital presentation due to serious hypoglycemia.

Hypertension

ACE Inhibitors vs ARBs for First-Line Hypertension Treatment

Cassandra Pardini, PharmD

July 30, 2021

Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines.

Arrhythmia

The Link Between Coffee Consumption and Arrhythmia Risk

Cassandra Pardini, PharmD

July 26, 2021

Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.

Heart Failure

Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored

Cassandra Pardini, PharmD

July 16, 2021

Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.

Metabolic

Risk of Muscle Problems Based on Statin Therapy Intensity Investigated

Cassandra Pardini, PharmD

July 2, 2021

Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.

Arrhythmia

Severe Abnormal Uterine Bleeding Risk With Anticoagulant Therapy Examined

Cassandra Pardini, PharmD

June 10, 2021

Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.

General Cardiology

Medicine Organizers Often Contain “One Pill Can Kill” Medications

Cassandra Pardini, PharmD

June 2, 2021

While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.

Metabolic

Fish Oil Products: Do The Serving Sizes Add Up to Cholesterol Benefits?

Cassandra Pardini, PharmD

May 25, 2020

Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.

Next post in Metabolic